Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good morning Mick
Nice post
Go $PMCB
I want 1M
Go $SIPC
$PMCB latest report
http://stonegateinc.com/reports/Pharma_Feb_2016.pdf
$GEQU Global Equity International Inc. Would Like to Welcome Mr. Kevin Wynn to Its Ever Growing Team
Source: InvestorsHub NewsWire
SOURCE: Global Equity International Inc.
Global Equity International Inc.
DUBAI, UNITED ARAB EMIRATES--(NewMediaWire - Feb 10, 2016) - Global Equity International, Inc. and subsidiaries (OTCQB: GEQU), a specialist consultancy firm with offices located in Dubai and London, and now also a physical presence in Frankfurt (Germany), is pleased to announce that today, Mr. Kevin Wynn has formally become the newest member of the Global Equity Partners Plc. team.
Mr. Wynn (https://www.linkedin.com/in/kevin-wynn-7715632a) brings a wealth of knowledge and additional focus to the Company's already rapidly growing portfolio of clients, while developing new business strategies, potential new avenues of funding and additional opportunities internationally. As an essential part of Global Equity's growing team, Kevin's extensive accomplishments and expertise will provide the Company with a valuable pipeline of new portfolio clients.
Kevin brings an impressive amount of experience from both an operational and capital raising perspective and has significant contacts across the financial markets. He has historically worked closely with numerous Private Equity, Institutional Investment Funds and International Property Developments Corporations in Europe and also in the United States. The Company is very confident that Kevin will attract tremendous new deal flow mainly from continental Europe as he is based in Frankfurt (Germany).
Patrick Dolan, Managing Director of Global Equity International Inc., said, "We look forward to Kevin's contribution to the Global Equity Partners team. We truly believe that he will be an asset to the Company that will not only support my role as managing director but also bring in a number of new quality portfolio clients seeking to raise substantial capital funding and/or a listing of their shares on a recognized stock exchange."
Kevin Wynn said, "Global Equity International Inc. is an exciting upwardly moving company with a very unique business model which is now proving itself to be both pragmatic and extremely successful. The Company is attracting unique and robust companies looking to raise substantial capital funding, often pre-IPO and is receiving quite a lot of attention from international funding sources that are looking to deploy capital into the Company's portfolio clients. I feel privileged to join such a team of professionals at Global Equity Partners."
About Kevin Wynn
Mr. Kevin Wynn currently resides in Frankfurt, Germany. He was born in the Bahamas in 1960 and was educated in London (United Kingdom) where he completed a B.A. Honors Degree in History from the University of Keele in Staffordshire (United Kingdom).
After completing Management Training at GEC in London he moved into publishing and then on to McGraw-Hill / Standard & Poors for 8 years, becoming the European and Mid East African sales and marketing director for "Platts" the Global Oil and Petrochemical Pricing and Information Service.
In the late 90s Kevin moved to Germany where he has been involved in Corporate Finance and Asset Management, lastly with Comval Asset Management AG in Frankfurt. There he worked on planning and capital raising on Commodity, Real-Estate, Timber, Agriculture and Environmental projects.
He also has worked as a project advisor for HP Law, a firm that specializes in corporate M&A, finance, Capital Markets, international taxation and fund management.
Kevin Wynn speaks fluent English and German and brings with him a wealth of contacts in the Private Banking and Asset Management sector.
About Global Equity International Inc. and subsidiaries
Global Equity International Inc., through its wholly owned subsidiary Global Equity Partners Plc., advises worldwide business leaders with their most critical decisions and opportunities pertaining to growth, capital needs, structure and the development of a global presence. With offices in Dubai and London, Global Equity has developed significant relationships in the US, UK, Central Europe, the Middle East and South East Asia to assist clients in realizing their full value and potential by bringing them to external capital and resources that place an emphasis on collaborative thinking. Furthermore, because Global Equity has offices in key financial centres of the world, they are able to introduce their clients to a unique opportunity of listing their shares on any one of the many stock exchanges worldwide. Global Equity Partners holds significant long-term equity positions in the companies that it represents.
Safe Harbour Statement
This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are no guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The company assumes no duty to update its forward-looking statements.
CONTACT INFORMATION
CONTACT:
Patrick V. Dolan
Managing Director
Tel + (44) 7917 383762 (UK)
Email: patrick@gepartnersplc.com
Enzo Taddei
CFO and Director
Tel + (1) 321 200 0142 (US)
Email: enzo@gepartnersplc.com
Kevin Wynn
Tel. + (49) 176 3914 5367 (Germany)
Email: kwynn@gepartnersplc.com
$GEQU Global Equity International Inc. Would Like to Welcome Mr. Kevin Wynn to Its Ever Growing Team
Source: InvestorsHub NewsWire
SOURCE: Global Equity International Inc.
Global Equity International Inc.
DUBAI, UNITED ARAB EMIRATES--(NewMediaWire - Feb 10, 2016) - Global Equity International, Inc. and subsidiaries (OTCQB: GEQU), a specialist consultancy firm with offices located in Dubai and London, and now also a physical presence in Frankfurt (Germany), is pleased to announce that today, Mr. Kevin Wynn has formally become the newest member of the Global Equity Partners Plc. team.
Mr. Wynn (https://www.linkedin.com/in/kevin-wynn-7715632a) brings a wealth of knowledge and additional focus to the Company's already rapidly growing portfolio of clients, while developing new business strategies, potential new avenues of funding and additional opportunities internationally. As an essential part of Global Equity's growing team, Kevin's extensive accomplishments and expertise will provide the Company with a valuable pipeline of new portfolio clients.
Kevin brings an impressive amount of experience from both an operational and capital raising perspective and has significant contacts across the financial markets. He has historically worked closely with numerous Private Equity, Institutional Investment Funds and International Property Developments Corporations in Europe and also in the United States. The Company is very confident that Kevin will attract tremendous new deal flow mainly from continental Europe as he is based in Frankfurt (Germany).
Patrick Dolan, Managing Director of Global Equity International Inc., said, "We look forward to Kevin's contribution to the Global Equity Partners team. We truly believe that he will be an asset to the Company that will not only support my role as managing director but also bring in a number of new quality portfolio clients seeking to raise substantial capital funding and/or a listing of their shares on a recognized stock exchange."
Kevin Wynn said, "Global Equity International Inc. is an exciting upwardly moving company with a very unique business model which is now proving itself to be both pragmatic and extremely successful. The Company is attracting unique and robust companies looking to raise substantial capital funding, often pre-IPO and is receiving quite a lot of attention from international funding sources that are looking to deploy capital into the Company's portfolio clients. I feel privileged to join such a team of professionals at Global Equity Partners."
About Kevin Wynn
Mr. Kevin Wynn currently resides in Frankfurt, Germany. He was born in the Bahamas in 1960 and was educated in London (United Kingdom) where he completed a B.A. Honors Degree in History from the University of Keele in Staffordshire (United Kingdom).
After completing Management Training at GEC in London he moved into publishing and then on to McGraw-Hill / Standard & Poors for 8 years, becoming the European and Mid East African sales and marketing director for "Platts" the Global Oil and Petrochemical Pricing and Information Service.
In the late 90s Kevin moved to Germany where he has been involved in Corporate Finance and Asset Management, lastly with Comval Asset Management AG in Frankfurt. There he worked on planning and capital raising on Commodity, Real-Estate, Timber, Agriculture and Environmental projects.
He also has worked as a project advisor for HP Law, a firm that specializes in corporate M&A, finance, Capital Markets, international taxation and fund management.
Kevin Wynn speaks fluent English and German and brings with him a wealth of contacts in the Private Banking and Asset Management sector.
About Global Equity International Inc. and subsidiaries
Global Equity International Inc., through its wholly owned subsidiary Global Equity Partners Plc., advises worldwide business leaders with their most critical decisions and opportunities pertaining to growth, capital needs, structure and the development of a global presence. With offices in Dubai and London, Global Equity has developed significant relationships in the US, UK, Central Europe, the Middle East and South East Asia to assist clients in realizing their full value and potential by bringing them to external capital and resources that place an emphasis on collaborative thinking. Furthermore, because Global Equity has offices in key financial centres of the world, they are able to introduce their clients to a unique opportunity of listing their shares on any one of the many stock exchanges worldwide. Global Equity Partners holds significant long-term equity positions in the companies that it represents.
Safe Harbour Statement
This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are no guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The company assumes no duty to update its forward-looking statements.
CONTACT INFORMATION
CONTACT:
Patrick V. Dolan
Managing Director
Tel + (44) 7917 383762 (UK)
Email: patrick@gepartnersplc.com
Enzo Taddei
CFO and Director
Tel + (1) 321 200 0142 (US)
Email: enzo@gepartnersplc.com
Kevin Wynn
Tel. + (49) 176 3914 5367 (Germany)
Email: kwynn@gepartnersplc.com
$ADVT Advantis Corp. Establishes Advantis Cannabis, LLC in Washington
Source: InvestorsHub NewsWire
SOURCE: Advantis Corp
Advantis Corp
SANTA ANA, CA--(NewMediaWire - Feb 10, 2016) - ADVANTIS CORPORATION (OTC PINK: ADVT) officially announced that they have established a new Advantis Cannabis, LLC subsidiary in Washington. Company consultants have been investigating logistics, laws, and prospective partners in Washington's legal cannabis market since last year. Last week Advantis Cannabis Corp. established a limited liability company with the same name (Advantis Cannabis, LLC) in the state of Oregon, after meeting with regulatory and environmental consultant, EARSI. EARSI has agreed to help facilitate the licensing, regulatory and environmental process for each subsidiary to establish the necessary footprint and develop the environmental and regulatory framework in each respective state the company establishes an LLC within. "We have been in discussions with several prospective partners in Washington," operational Vice President, Geoffrey Broderick, said. "Some of these prospective partners already hold the proper licensing and have fruitful agricultural operations that can offer a turnkey solution to entering the Washington marijuana marketplace." Washington's law specifies that an entity can be licensed as a retail establishment or as a producer and/or processor. Broderick made no direct comment about which license(s) the company will pursue.
This is the second consecutive announcement about Advantis reaching into the marijuana marketplace through its subsidiaries. Broderick expanded upon the company strategy, stating, "We are expanding our reach into these cannabis friendly states one at a time, and are not stopping. We will be establishing a foothold in every one of these states, while keeping an eye on those yet to come." Broderick later commented that these are the first two in a strategic process that will create a national brand name. Company Director, Woo Kim, shared his excitement about the Washington marijuana marketplace, and painted a picture of how the company will establish itself as an industry leader, saying, "It is with partners like Natural Elements Group, Inc. that we will firmly establish an efficient, proven agricultural process that yields a superior product." He said, "Many others may grow well, but this process is cost efficient and the end product is consistently reliable in terms of flavor, texture, smell and potency. Their process for creating flavorful edibles, vapors, extracts, and beverages is unmatched. An excellent product, efficient and reliable processes, and excellent people to work with. This is how you create a brand name."
ABOUT Advantis Corporation
Advantis Corporation (OTC PINK: ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes domestic and international partnerships with businesses that develop and sell proprietary consumer products and services. Product lines for consumer health care, music and entertainment sectors are in development.
Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Advantis Corp. Establishes Advantis Cannabis, LLC in Washington Securities Exchange Act of 1934 because it is not registered under either Act.
CONTACT INFORMATION
For further information, contact:
Media Relations Contact
Name: Woo Kim
Director
Organization: Advantis Corporation
Phone: 800-891-0508
Address: 6 Hutton Center Dr. Santa Ana, Ca 92704
E-mail: Info@advantis.corp
$ADVT Advantis Corp. Establishes Advantis Cannabis, LLC in Washington
Source: InvestorsHub NewsWire
SOURCE: Advantis Corp
Advantis Corp
SANTA ANA, CA--(NewMediaWire - Feb 10, 2016) - ADVANTIS CORPORATION (OTC PINK: ADVT) officially announced that they have established a new Advantis Cannabis, LLC subsidiary in Washington. Company consultants have been investigating logistics, laws, and prospective partners in Washington's legal cannabis market since last year. Last week Advantis Cannabis Corp. established a limited liability company with the same name (Advantis Cannabis, LLC) in the state of Oregon, after meeting with regulatory and environmental consultant, EARSI. EARSI has agreed to help facilitate the licensing, regulatory and environmental process for each subsidiary to establish the necessary footprint and develop the environmental and regulatory framework in each respective state the company establishes an LLC within. "We have been in discussions with several prospective partners in Washington," operational Vice President, Geoffrey Broderick, said. "Some of these prospective partners already hold the proper licensing and have fruitful agricultural operations that can offer a turnkey solution to entering the Washington marijuana marketplace." Washington's law specifies that an entity can be licensed as a retail establishment or as a producer and/or processor. Broderick made no direct comment about which license(s) the company will pursue.
This is the second consecutive announcement about Advantis reaching into the marijuana marketplace through its subsidiaries. Broderick expanded upon the company strategy, stating, "We are expanding our reach into these cannabis friendly states one at a time, and are not stopping. We will be establishing a foothold in every one of these states, while keeping an eye on those yet to come." Broderick later commented that these are the first two in a strategic process that will create a national brand name. Company Director, Woo Kim, shared his excitement about the Washington marijuana marketplace, and painted a picture of how the company will establish itself as an industry leader, saying, "It is with partners like Natural Elements Group, Inc. that we will firmly establish an efficient, proven agricultural process that yields a superior product." He said, "Many others may grow well, but this process is cost efficient and the end product is consistently reliable in terms of flavor, texture, smell and potency. Their process for creating flavorful edibles, vapors, extracts, and beverages is unmatched. An excellent product, efficient and reliable processes, and excellent people to work with. This is how you create a brand name."
ABOUT Advantis Corporation
Advantis Corporation (OTC PINK: ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes domestic and international partnerships with businesses that develop and sell proprietary consumer products and services. Product lines for consumer health care, music and entertainment sectors are in development.
Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Advantis Corp. Establishes Advantis Cannabis, LLC in Washington Securities Exchange Act of 1934 because it is not registered under either Act.
CONTACT INFORMATION
For further information, contact:
Media Relations Contact
Name: Woo Kim
Director
Organization: Advantis Corporation
Phone: 800-891-0508
Address: 6 Hutton Center Dr. Santa Ana, Ca 92704
E-mail: Info@advantis.corp
$AMBS Various Development Advancements for Targeted Treatment Therapies for Rare Diseases & Disorders Lead to Newest Orphan Drug
Source: InvestorsHub NewsWire
Various Development Advancements for Targeted Treatment Therapies for Rare Diseases & Disorders Lead to Newest Orphan Drug Designations by the U.S. FDA
Coral Springs, FL - (February 10, 2016) - Today's latest Orphan Drug Designations become vitally important in the development of targeted treatment therapies when granted by the FDA to novel drugs and biologics which are defined as those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders. Biotech companies with recent developments of market importance are Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), Cerus Corporation (NASDAQ: CERS), Medivation, Inc. (NASDAQ: MDVN), Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) and Celldex Therapeutics, Inc. (NASDAQ: CLDX).
Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, today announced that it has received orphan drug designation from the US FDA for Eltoprazine in the treatment of Parkinsons disease levodopa-induced dyskinesia (PD-LID). Amarantus published positive results from a Phase 2 initial proof-of-concept clinical study in February of 2015 in the journal Brain, and highlighted the publication of two independent peer-reviewed scientific publications describing the mechanism of action of eltoprazine for the treatment of PD LID in August of 2015 and December 2016.
Read the full Amarantus (AMBS) Press Release at http://financialnewsmedia.com/profiles/ambs.html
The grant of this orphan drug designation for eltoprazine in PD-LID squarely positions Amarantus as an orphan drug company, as each of our pipeline candidates in our therapeutics division has received such designations from the FDA for one or more indications, said Gerald E. Commissiong, President & CEO of Amarantus. PD-LID is a tremendously debilitating disorder, and we will now begin evaluating expedited pathways to market for eltoprazine that may now be afforded by the orphan drug designation. The FDA Orphan Drug Designation program provides a special status to drugs and biologics intended to treat, diagnose or prevent so-called orphan diseases and disorders that affect fewer than 200,000 people in the U.S. This designation provides for a seven year marketing exclusivity period against competition, as well as certain incentives, including federal grants, tax credits and a waiver of PDUFA filing fees.
In other Biotech developments to watch this week: Cerus Corporation (NASDAQ: CERS) announced that the American Red Cross has signed a multi-year purchase agreement for the INTERCEPT Blood System for platelets and plasma, which inactivates a broad spectrum of viruses, gram-positive and gram-negative bacteria, spirochetes, parasites and leukocytes and is intended to reduce the risk of transfusion-transmitted infection (TTI) in platelet and plasma components. The American Red Cross is the largest supplier of blood products in the United States. The Red Cross collects and processes approximately 40 percent of the blood supply, distributing about 780,000 platelet and 1.1 million plasma units last year to nearly 2,600 hospitals and transfusion centers nationwide.
Astellas US LLC, a United States (U.S.) subsidiary of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. (NASDAQ: MDVN) recently announced that results from the STRIVE trial of enzalutamide compared to bicalutamide in men with castration-resistant prostate cancer (CRPC) were published in the Journal of Clinical Oncology. The article, titled, "Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial," appears in the January 25, 2016 online issue and will be published in a future print issue of the journal
Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) back in January provided a summary of 2015 corporate highlights and planned future milestones. Adamas, which is developing new medicines for chronic neurological disorders, utilizes its technology platform to improve the pharmacokinetics profiles of approved drugs, alone and in fixed-dose combinations. The company is developing ADS-5102 for two indications: levodopa-induced dyskinesia (LID), a complication associated with the treatment of Parkinsons disease, and major symptoms associated with multiple sclerosis (MS) in patients with walking impairment. Adamas also has ADS-4101 in preclinical development for epilepsy (partial onset seizures). In addition, the company has a partnership with Allergan for two approved products, Namzaric and Namenda XR, which are marketed in the U.S. by Allergan.
Celldex Therapeutics, Inc. (NASDAQ: CLDX) develops targeted therapeutics to address devastating diseases for which available treatments are inadequate. The Company's pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. CLDX was one of the leaders yesterday for the Biotech sector closing up at $6.98 on over 3.2Mil shares traded by the market close.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at financialnewsmedia.com. Follow us on Facebook: facebook.com/financialnewsmedia and Twitter: twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand nine hundred dollars for news coverage of the current press release issued by Amarantus BioScience Holdings, Inc. by the company FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: (954)345-0611
URL: www.financialnewsmedia.com
Source: FN Media Group
$AMBS Various Development Advancements for Targeted Treatment Therapies for Rare Diseases & Disorders Lead to Newest Orphan Drug
Source: InvestorsHub NewsWire
Various Development Advancements for Targeted Treatment Therapies for Rare Diseases & Disorders Lead to Newest Orphan Drug Designations by the U.S. FDA
Coral Springs, FL - (February 10, 2016) - Today's latest Orphan Drug Designations become vitally important in the development of targeted treatment therapies when granted by the FDA to novel drugs and biologics which are defined as those intended for the safe and effective treatment, diagnosis or prevention of rare diseases/disorders. Biotech companies with recent developments of market importance are Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), Cerus Corporation (NASDAQ: CERS), Medivation, Inc. (NASDAQ: MDVN), Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) and Celldex Therapeutics, Inc. (NASDAQ: CLDX).
Amarantus BioScience Holdings, Inc. (OTCQB: AMBS), a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, today announced that it has received orphan drug designation from the US FDA for Eltoprazine in the treatment of Parkinsons disease levodopa-induced dyskinesia (PD-LID). Amarantus published positive results from a Phase 2 initial proof-of-concept clinical study in February of 2015 in the journal Brain, and highlighted the publication of two independent peer-reviewed scientific publications describing the mechanism of action of eltoprazine for the treatment of PD LID in August of 2015 and December 2016.
Read the full Amarantus (AMBS) Press Release at http://financialnewsmedia.com/profiles/ambs.html
The grant of this orphan drug designation for eltoprazine in PD-LID squarely positions Amarantus as an orphan drug company, as each of our pipeline candidates in our therapeutics division has received such designations from the FDA for one or more indications, said Gerald E. Commissiong, President & CEO of Amarantus. PD-LID is a tremendously debilitating disorder, and we will now begin evaluating expedited pathways to market for eltoprazine that may now be afforded by the orphan drug designation. The FDA Orphan Drug Designation program provides a special status to drugs and biologics intended to treat, diagnose or prevent so-called orphan diseases and disorders that affect fewer than 200,000 people in the U.S. This designation provides for a seven year marketing exclusivity period against competition, as well as certain incentives, including federal grants, tax credits and a waiver of PDUFA filing fees.
In other Biotech developments to watch this week: Cerus Corporation (NASDAQ: CERS) announced that the American Red Cross has signed a multi-year purchase agreement for the INTERCEPT Blood System for platelets and plasma, which inactivates a broad spectrum of viruses, gram-positive and gram-negative bacteria, spirochetes, parasites and leukocytes and is intended to reduce the risk of transfusion-transmitted infection (TTI) in platelet and plasma components. The American Red Cross is the largest supplier of blood products in the United States. The Red Cross collects and processes approximately 40 percent of the blood supply, distributing about 780,000 platelet and 1.1 million plasma units last year to nearly 2,600 hospitals and transfusion centers nationwide.
Astellas US LLC, a United States (U.S.) subsidiary of Tokyo-based Astellas Pharma Inc. (TSE:4503), and Medivation, Inc. (NASDAQ: MDVN) recently announced that results from the STRIVE trial of enzalutamide compared to bicalutamide in men with castration-resistant prostate cancer (CRPC) were published in the Journal of Clinical Oncology. The article, titled, "Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial," appears in the January 25, 2016 online issue and will be published in a future print issue of the journal
Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS) back in January provided a summary of 2015 corporate highlights and planned future milestones. Adamas, which is developing new medicines for chronic neurological disorders, utilizes its technology platform to improve the pharmacokinetics profiles of approved drugs, alone and in fixed-dose combinations. The company is developing ADS-5102 for two indications: levodopa-induced dyskinesia (LID), a complication associated with the treatment of Parkinsons disease, and major symptoms associated with multiple sclerosis (MS) in patients with walking impairment. Adamas also has ADS-4101 in preclinical development for epilepsy (partial onset seizures). In addition, the company has a partnership with Allergan for two approved products, Namzaric and Namenda XR, which are marketed in the U.S. by Allergan.
Celldex Therapeutics, Inc. (NASDAQ: CLDX) develops targeted therapeutics to address devastating diseases for which available treatments are inadequate. The Company's pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. CLDX was one of the leaders yesterday for the Biotech sector closing up at $6.98 on over 3.2Mil shares traded by the market close.
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at financialnewsmedia.com. Follow us on Facebook: facebook.com/financialnewsmedia and Twitter: twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated one thousand nine hundred dollars for news coverage of the current press release issued by Amarantus BioScience Holdings, Inc. by the company FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: (954)345-0611
URL: www.financialnewsmedia.com
Source: FN Media Group
$MINE Beverage Industry Growth Outlook Strengthens as Rapidly Growing Flavored & Sparkling Water Market Dominates a Shift in Consumer
Source: InvestorsHub NewsWire
Beverage Industry Growth Outlook Strengthens as Rapidly Growing Flavored & Sparkling Water Market Dominates a Shift in Consumer Preference
Coral Springs, FL (February 10, 2016) - The global market for specialty/sparkling/flavored water products surged in 2015 while some industry experts forecast the market to double over the next 5 years as Beverage Manufactures race to meet consumer demand. Beverage companies of interest with recent developments are Minerco, Inc. (OTC:MINE), The Coca-Cola Company (NYSE: KO), PepsiCo Inc. (NYSE: PEP), Cott Corporation (NYSE: COT) and Dr Pepper Snapple (NYSE: DPS).
Minerco, Inc. (OTC:MINE), parent company of Athena Brands, Inc., announced the completion of the acquisition of VitaminFIZZ, the vitamin enhanced sparkling water brand. This acquisition by Athena Brands, delivering 100% ownership and control of VitaminFIZZ, is followed by the strategic expansion of VitaminFIZZ flavors and functionality. The companys 100% ownership of VitaminFIZZ provides for the planned expansion of the VitaminFIZZ brand. As foreshadowed in a recent Beverage Industry article titled VitaminFIZZ's taste profile helps sparkling water brand standout - Distribution, lineup expansions in store for the future, VitaminFIZZ is poised for geographical expansion from its established Southern California base with additions to the brand lineup to further differentiate VitaminFIZZ in the category.
Read the full Minerco (MINE) Press Release at http://www.financialnewsmedia.com/profiles/mine.html
After feedback from national retail and their agents / brokers, the VitaminFIZZ brand is expanding to include additional flavors and added functionality. The expanded skus include new formulations containing caffeine, amounts equivalent to a typical diet soda, to further differentiate the brand and grow its consumer base. The expanded formulations packaging is also being fashioned to clearly identify the caffeine functionality. The caffeine packaging is slightly more masculine for dual placement in the sparkling water and soda categories while positioning the brand for national convenience chain opportunities. The closing of the acquisition of VitaminFIZZ is a major event for the company for a multitude of reasons. Foremost, our company and shareholders rightfully own 100% of the emerging, best tasting and enhanced sparkling water brand: VitaminFIZZ. With 100% ownership of the VitaminFIZZ brand and its intellectual property, we are aggressively expanding the brands offerings to cater to a national audience.
The Coca-Cola Company (NYSE: KO) announced that it is accelerating the pace and scale of its bottler refranchising efforts with plans to refranchise 100% of Company-owned North America bottling territories by the end of 2017, including all cold-fill production facilities. The Company has also entered into a non-binding letter of intent to refranchise Company-owned bottling operations in China to existing partners China Foods Limited, part of COFCO Limited, and Swire Beverage Holdings Limited, building on other recent global refranchising initiatives in Europe and Africa. The Coca-Cola Company is the world's largest beverage company, refreshing consumers with more than 500 sparkling and still brands.
Monster Energy, a Monster Beverage Corporation company (NASDAQ: MNST), back in Janauary launched a new variant under the name of Monster Ultra in a new can size exclusively for the on-trade. The lighter-tasting, zero-calorie and sugar-free product is available in a new 355ml embossed can that aims to create a higher-value feel. Monster Ultra will offer customers greater volume and will also benefit operators by increasing the number of servings per single can.
In a move that may well prove to be every bit as appealing as New Coke, PepsiCo Inc. (NYSE: PEP) is opening a so-called craft drink bar and restaurant in the ultrahip Meatpacking District named Kola House. Problems one and two: the address is in Chelsea, and, you cant announce youre going to be trendy, especially by invoking an area that is so very last Market Crash. There is a long history of beverage makers owning their own watering holes: Think most of the U.K.s pubs, Bacardi bars on various continents and iconic Coca-Cola retail emporia in malls and on the Las Vegas strip. But while Pepsi may be successful and popular, it simply isnt iconic. Try as it might, nobody wants an antique Pepsi bottle. Its just not warm and fuzzy. Enter fizzy, snazzy, buzzy and hip. (sounds like a really unfortunate law firm or rock band on Nickelodeon). They intend to focus on the Kola nut and its sweetened drinkables, seeking to be media worthy in this new multi-platform age.
Cott Corporation (NYSE: COT) announced recently that it has closed its previously announced acquisition of Aquaterra, Canada's oldest and largest direct-to-consumer home and office water delivery business for approximately C$62 million (approximately $45 million USD on the closing date). The acquisition was funded using cash on hand as well as borrowings under Cott's asset based lending facility.
UBS reiterates a Neutral rating on Dr Pepper Snapple (NYSE: DPS), and raised the price target to $90.00 (from $89.00), ahead of the company's 4Q release and board meeting. The board meeting may be hidden from investor view amidst the company's earnings. Given another busy earnings season, UBS believes that some investors may have lost sight of the possibility of a forthcoming dividend raise. UBS expects the DPS Board to meet mid-week, which may result in a further dividend increase announcement shortly thereafter. Read the full article here
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at financialnewsmedia.com. Follow us on Facebook: facebook.com/financialnewsmedia and Twitter: twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated three thousand eight hundred dollars for news coverage of the current press release issued by Minerco, Inc. by a non-affiliated third party. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: (954)345-0611
URL: www.financialnewsmedia.com
Source: FN Media Group
$MINE Beverage Industry Growth Outlook Strengthens as Rapidly Growing Flavored & Sparkling Water Market Dominates a Shift in Consumer
Source: InvestorsHub NewsWire
Beverage Industry Growth Outlook Strengthens as Rapidly Growing Flavored & Sparkling Water Market Dominates a Shift in Consumer Preference
Coral Springs, FL (February 10, 2016) - The global market for specialty/sparkling/flavored water products surged in 2015 while some industry experts forecast the market to double over the next 5 years as Beverage Manufactures race to meet consumer demand. Beverage companies of interest with recent developments are Minerco, Inc. (OTC:MINE), The Coca-Cola Company (NYSE: KO), PepsiCo Inc. (NYSE: PEP), Cott Corporation (NYSE: COT) and Dr Pepper Snapple (NYSE: DPS).
Minerco, Inc. (OTC:MINE), parent company of Athena Brands, Inc., announced the completion of the acquisition of VitaminFIZZ, the vitamin enhanced sparkling water brand. This acquisition by Athena Brands, delivering 100% ownership and control of VitaminFIZZ, is followed by the strategic expansion of VitaminFIZZ flavors and functionality. The companys 100% ownership of VitaminFIZZ provides for the planned expansion of the VitaminFIZZ brand. As foreshadowed in a recent Beverage Industry article titled VitaminFIZZ's taste profile helps sparkling water brand standout - Distribution, lineup expansions in store for the future, VitaminFIZZ is poised for geographical expansion from its established Southern California base with additions to the brand lineup to further differentiate VitaminFIZZ in the category.
Read the full Minerco (MINE) Press Release at http://www.financialnewsmedia.com/profiles/mine.html
After feedback from national retail and their agents / brokers, the VitaminFIZZ brand is expanding to include additional flavors and added functionality. The expanded skus include new formulations containing caffeine, amounts equivalent to a typical diet soda, to further differentiate the brand and grow its consumer base. The expanded formulations packaging is also being fashioned to clearly identify the caffeine functionality. The caffeine packaging is slightly more masculine for dual placement in the sparkling water and soda categories while positioning the brand for national convenience chain opportunities. The closing of the acquisition of VitaminFIZZ is a major event for the company for a multitude of reasons. Foremost, our company and shareholders rightfully own 100% of the emerging, best tasting and enhanced sparkling water brand: VitaminFIZZ. With 100% ownership of the VitaminFIZZ brand and its intellectual property, we are aggressively expanding the brands offerings to cater to a national audience.
The Coca-Cola Company (NYSE: KO) announced that it is accelerating the pace and scale of its bottler refranchising efforts with plans to refranchise 100% of Company-owned North America bottling territories by the end of 2017, including all cold-fill production facilities. The Company has also entered into a non-binding letter of intent to refranchise Company-owned bottling operations in China to existing partners China Foods Limited, part of COFCO Limited, and Swire Beverage Holdings Limited, building on other recent global refranchising initiatives in Europe and Africa. The Coca-Cola Company is the world's largest beverage company, refreshing consumers with more than 500 sparkling and still brands.
Monster Energy, a Monster Beverage Corporation company (NASDAQ: MNST), back in Janauary launched a new variant under the name of Monster Ultra in a new can size exclusively for the on-trade. The lighter-tasting, zero-calorie and sugar-free product is available in a new 355ml embossed can that aims to create a higher-value feel. Monster Ultra will offer customers greater volume and will also benefit operators by increasing the number of servings per single can.
In a move that may well prove to be every bit as appealing as New Coke, PepsiCo Inc. (NYSE: PEP) is opening a so-called craft drink bar and restaurant in the ultrahip Meatpacking District named Kola House. Problems one and two: the address is in Chelsea, and, you cant announce youre going to be trendy, especially by invoking an area that is so very last Market Crash. There is a long history of beverage makers owning their own watering holes: Think most of the U.K.s pubs, Bacardi bars on various continents and iconic Coca-Cola retail emporia in malls and on the Las Vegas strip. But while Pepsi may be successful and popular, it simply isnt iconic. Try as it might, nobody wants an antique Pepsi bottle. Its just not warm and fuzzy. Enter fizzy, snazzy, buzzy and hip. (sounds like a really unfortunate law firm or rock band on Nickelodeon). They intend to focus on the Kola nut and its sweetened drinkables, seeking to be media worthy in this new multi-platform age.
Cott Corporation (NYSE: COT) announced recently that it has closed its previously announced acquisition of Aquaterra, Canada's oldest and largest direct-to-consumer home and office water delivery business for approximately C$62 million (approximately $45 million USD on the closing date). The acquisition was funded using cash on hand as well as borrowings under Cott's asset based lending facility.
UBS reiterates a Neutral rating on Dr Pepper Snapple (NYSE: DPS), and raised the price target to $90.00 (from $89.00), ahead of the company's 4Q release and board meeting. The board meeting may be hidden from investor view amidst the company's earnings. Given another busy earnings season, UBS believes that some investors may have lost sight of the possibility of a forthcoming dividend raise. UBS expects the DPS Board to meet mid-week, which may result in a further dividend increase announcement shortly thereafter. Read the full article here
FinancialNewsMedia.com is leading provider of third party publishing & news dissemination services. If you would like more information regarding our news coverage solutions, please visit financialnewsmedia.com for more details. Get an edge on the market with our Premium News Alerts that are FREE for a limited time at financialnewsmedia.com. Follow us on Facebook: facebook.com/financialnewsmedia and Twitter: twitter.com/FNMgroup.
DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG has been compensated three thousand eight hundred dollars for news coverage of the current press release issued by Minerco, Inc. by a non-affiliated third party. FNMG HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.
Contact Information:
Company: FN Media Group, LLC
Contact email: editor@financialnewsmedia.com
U.S. Phone: (954)345-0611
URL: www.financialnewsmedia.com
Source: FN Media Group
$FDBL Friendable Invites Users to Beta Test New Android App as Launch Date Draws Near
Source: InvestorsHub NewsWire
SOURCE: Friendable, Inc.
Friendable, Inc.
CAMPBELL, CA--(NewMediaWire - Feb 10, 2016) - Friendable, Inc. (OTC PINK: FDBL) (the "Company"), a fully reporting Company positioned at the intersection of social networks and location based connections, is pleased to announce that it is now inviting users to participate in a beta test of the Android version of its popular app.
Via the link provided below, Friendable will be selecting a group of Google/Android smartphone users to test and provide additional feedback to expedite completion of the final version of the app. The Android platform has afforded Friendable with the opportunity to design some fun and unique features not currently available to iPhone/iOS Friendable users.
"We are eager to present the Friendable app to the enormous universe of Android users and the market in general," stated Robert Rositano, Jr., CEO, Friendable, Inc. "It has always been our strategic plan to first develop, penetrate and prove concept on the Apple iOS platform and I now believe the massive Google/Android marketplace is in for a very big surprise with our coming release."
"With further validation and feedback from our beta users, we will soon be Friendable to Android's billion+ users," added Rositano. "Apple was just the beginning."
Please click the link below to submit your interest in becoming a beta test user of Friendable, Android version. The company will review and approve a group of beta testers based on the information provided in the form and be in touch with all chosen users with instructions on where to go to download the app, as well as where and how to send your feedback/comments.
Android Beta Test Submission link:
http://www.friendable.com/Androidbeta
For more information about Friendable, Inc. please visit:
www.Friendable.com
For Additional Investor and to Receive Company Updates:
http://www.friendable.com/presentation
http://www.friendable.com/fdbloptin
Visit our social media properties at:
Facebook: http://facebook.com/friendable
Twitter: twitter.com/friendableapp
Instagram: instagram.com/friendableapp
About Friendable:
Friendable recognizes that "Everything starts with Friendship" and the way to make connections and meet new people continues to evolve through new technologies and devices that make it all possible. Today just about everyone is on the move and interacting online with their mobile devices, creating dynamic opportunities to find and explore new experiences with location specific accuracy.
Friendable provides its vast mobile community of users with the freedom to meet new people, hang out with current friends, explore exciting venues and interact in social activities based around shared interests and location, transforming mobile interactions into a real-life social experiences. Friendable bridges our mobile community of users with the meeting of new friends, building relationships and connecting them with local venues or events tied to their interests, which presents newfound ways for them to interact and hang out.
Meeting new people and making connections has grown, where the modern meaning of "being social" or "meeting up," now includes opportunities to meet through mobile apps. The result of these interactions produces hyper-local advertising opportunities, allowing Friendable to act as both a friend finder and concierge using nearby locations to identify activities, events and businesses that may provide the entertainment they are seeking.
Making friends through a mobile app allows people of various backgrounds to connect through common interests and engage in fresh experiences while cultivating deep relationships. Meet people where you want, when you want, and show the world that you're Friendable - Everything starts with friendship!
Join Friendable today and let someone know what you're "Friendable" for!
Cautionary Language Concerning Forward-Looking Statements
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected by Friendable, Inc. The iTunes rankings should not be construed as an indication in any way whatsoever of the future value of the Friendable's common stock or its present or future financial condition. The public filings of Friendable, Inc. made with the Securities and Exchange Commission may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Friendable, Inc. cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, Friendable, Inc. does not undertake, and Friendable, Inc. specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
CONTACT INFORMATION
CONTACT:
Investor Relations & Financial Media:
I.M.I.
888-216-3595
info@integrityir.com
All other media inquiries:
EJ Media Group
Jenna Toder
(212) 518-4771 x123
jenna@ejmediagroup.com
COMPANY:
Friendable, Inc.
(855) 473-7473
Info@friendable.com
$FDBL Friendable Invites Users to Beta Test New Android App as Launch Date Draws Near
Source: InvestorsHub NewsWire
SOURCE: Friendable, Inc.
Friendable, Inc.
CAMPBELL, CA--(NewMediaWire - Feb 10, 2016) - Friendable, Inc. (OTC PINK: FDBL) (the "Company"), a fully reporting Company positioned at the intersection of social networks and location based connections, is pleased to announce that it is now inviting users to participate in a beta test of the Android version of its popular app.
Via the link provided below, Friendable will be selecting a group of Google/Android smartphone users to test and provide additional feedback to expedite completion of the final version of the app. The Android platform has afforded Friendable with the opportunity to design some fun and unique features not currently available to iPhone/iOS Friendable users.
"We are eager to present the Friendable app to the enormous universe of Android users and the market in general," stated Robert Rositano, Jr., CEO, Friendable, Inc. "It has always been our strategic plan to first develop, penetrate and prove concept on the Apple iOS platform and I now believe the massive Google/Android marketplace is in for a very big surprise with our coming release."
"With further validation and feedback from our beta users, we will soon be Friendable to Android's billion+ users," added Rositano. "Apple was just the beginning."
Please click the link below to submit your interest in becoming a beta test user of Friendable, Android version. The company will review and approve a group of beta testers based on the information provided in the form and be in touch with all chosen users with instructions on where to go to download the app, as well as where and how to send your feedback/comments.
Android Beta Test Submission link:
http://www.friendable.com/Androidbeta
For more information about Friendable, Inc. please visit:
www.Friendable.com
For Additional Investor and to Receive Company Updates:
http://www.friendable.com/presentation
http://www.friendable.com/fdbloptin
Visit our social media properties at:
Facebook: http://facebook.com/friendable
Twitter: twitter.com/friendableapp
Instagram: instagram.com/friendableapp
About Friendable:
Friendable recognizes that "Everything starts with Friendship" and the way to make connections and meet new people continues to evolve through new technologies and devices that make it all possible. Today just about everyone is on the move and interacting online with their mobile devices, creating dynamic opportunities to find and explore new experiences with location specific accuracy.
Friendable provides its vast mobile community of users with the freedom to meet new people, hang out with current friends, explore exciting venues and interact in social activities based around shared interests and location, transforming mobile interactions into a real-life social experiences. Friendable bridges our mobile community of users with the meeting of new friends, building relationships and connecting them with local venues or events tied to their interests, which presents newfound ways for them to interact and hang out.
Meeting new people and making connections has grown, where the modern meaning of "being social" or "meeting up," now includes opportunities to meet through mobile apps. The result of these interactions produces hyper-local advertising opportunities, allowing Friendable to act as both a friend finder and concierge using nearby locations to identify activities, events and businesses that may provide the entertainment they are seeking.
Making friends through a mobile app allows people of various backgrounds to connect through common interests and engage in fresh experiences while cultivating deep relationships. Meet people where you want, when you want, and show the world that you're Friendable - Everything starts with friendship!
Join Friendable today and let someone know what you're "Friendable" for!
Cautionary Language Concerning Forward-Looking Statements
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected by Friendable, Inc. The iTunes rankings should not be construed as an indication in any way whatsoever of the future value of the Friendable's common stock or its present or future financial condition. The public filings of Friendable, Inc. made with the Securities and Exchange Commission may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. Friendable, Inc. cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, Friendable, Inc. does not undertake, and Friendable, Inc. specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.
CONTACT INFORMATION
CONTACT:
Investor Relations & Financial Media:
I.M.I.
888-216-3595
info@integrityir.com
All other media inquiries:
EJ Media Group
Jenna Toder
(212) 518-4771 x123
jenna@ejmediagroup.com
COMPANY:
Friendable, Inc.
(855) 473-7473
Info@friendable.com
$BCCI Baristas to Launch Affordable Keurig 2.0 Compatible Single Serve Cup Machines
Source: InvestorsHub NewsWire
SOURCE: Baristas Coffee Company, Inc.
Baristas Coffee Company, Inc.
SEATTLE, WA--(NewMediaWire - Feb 10, 2016) - Baristas Coffee Company, Inc. (OTCQB: BCCI), "Seattle's World Famous Costume Coffee," announced today that it is launching an affordable Baristas single serve coffee machine compatible with the Keurig® 2.0 K-Cup® Brewing System. The Single serve machine is expected to retail at 39.99 and will be available through Baristas growing distribution in the US and in Mexico.
The new machine is expected to be available on shelves and online by the end of March. The Baristas brewing machine is much more affordable than other machines compatible with the Keurig® 2.0 K-Cup® brewing system, allowing a greater number of consumers access to the wildly successful format and to Baristas White Coffee single serve cups.
White Coffee is a rarity and is developed using a slow and low heat roast that preserves a much higher caffeine level than a traditional roast. Because the beans have been under-roasted, white coffee has a lighter taste than traditional coffee and is described as both neutral and nutty. Both Baristas White Coffee and Espresso Roast Single Serve Cups are available and utilize Baristas award winning five bean variety of pure Arabica beans that have been hand selected and individually roasted to touch all seven parts of the taste experience in the perfect combination.
Baristas sold out its initial product run of white coffee in the first day it was introduced and then sold out on Amazon on the first day as well, where it is the only product of its type available. It has also been approved to export to Mexico the only White Coffee single serve cups compatible with the Keurig® K-Cup® Brewing System 2.0 available anywhere in Mexico.
Barry Henthorn, CEO, stated: "Baristas introducing a quality brewer that can be afforded by the masses expands the product offering and allows us to bundle our Espresso Roast and unique White Coffee Cups, allowing access to a growing coffee experience. The availability of a complete offering has aided in our ability to expand into retail distribution."
About Baristas Coffee Company (BCCI): Headquartered in the Seattle, Washington area, Baristas Coffee Company, Inc. was formed to create a national brand of drive-thru espresso stands. BCCI is accomplishing this by acquiring established businesses that fit its model, opening new locations, and by franchising. Baristas has separated itself from the competition with its "theme" of joining attractive female baristas in entertaining costumes preparing the finest beverages available on the market. Baristas can currently be found throughout the greater Seattle area as well as in Florida, and Montana. Your state, Coming Soon!
For more information on this fascinating concept please visit us at www.baristas.tv
CONTACT INFORMATION
For Investor Relations Contact:
Barry Henthorn
barry@baristas.tv
(206)579-0222
$BCCI Baristas to Launch Affordable Keurig 2.0 Compatible Single Serve Cup Machines
Source: InvestorsHub NewsWire
SOURCE: Baristas Coffee Company, Inc.
Baristas Coffee Company, Inc.
SEATTLE, WA--(NewMediaWire - Feb 10, 2016) - Baristas Coffee Company, Inc. (OTCQB: BCCI), "Seattle's World Famous Costume Coffee," announced today that it is launching an affordable Baristas single serve coffee machine compatible with the Keurig® 2.0 K-Cup® Brewing System. The Single serve machine is expected to retail at 39.99 and will be available through Baristas growing distribution in the US and in Mexico.
The new machine is expected to be available on shelves and online by the end of March. The Baristas brewing machine is much more affordable than other machines compatible with the Keurig® 2.0 K-Cup® brewing system, allowing a greater number of consumers access to the wildly successful format and to Baristas White Coffee single serve cups.
White Coffee is a rarity and is developed using a slow and low heat roast that preserves a much higher caffeine level than a traditional roast. Because the beans have been under-roasted, white coffee has a lighter taste than traditional coffee and is described as both neutral and nutty. Both Baristas White Coffee and Espresso Roast Single Serve Cups are available and utilize Baristas award winning five bean variety of pure Arabica beans that have been hand selected and individually roasted to touch all seven parts of the taste experience in the perfect combination.
Baristas sold out its initial product run of white coffee in the first day it was introduced and then sold out on Amazon on the first day as well, where it is the only product of its type available. It has also been approved to export to Mexico the only White Coffee single serve cups compatible with the Keurig® K-Cup® Brewing System 2.0 available anywhere in Mexico.
Barry Henthorn, CEO, stated: "Baristas introducing a quality brewer that can be afforded by the masses expands the product offering and allows us to bundle our Espresso Roast and unique White Coffee Cups, allowing access to a growing coffee experience. The availability of a complete offering has aided in our ability to expand into retail distribution."
About Baristas Coffee Company (BCCI): Headquartered in the Seattle, Washington area, Baristas Coffee Company, Inc. was formed to create a national brand of drive-thru espresso stands. BCCI is accomplishing this by acquiring established businesses that fit its model, opening new locations, and by franchising. Baristas has separated itself from the competition with its "theme" of joining attractive female baristas in entertaining costumes preparing the finest beverages available on the market. Baristas can currently be found throughout the greater Seattle area as well as in Florida, and Montana. Your state, Coming Soon!
For more information on this fascinating concept please visit us at www.baristas.tv
CONTACT INFORMATION
For Investor Relations Contact:
Barry Henthorn
barry@baristas.tv
(206)579-0222
$EQLB EQ Labs Announces Timbaland’s Appearance in Las Vegas Supporting LastShot
Source: FSCwire
EQ Labs Announces Timbaland’s Appearance in Las Vegas Supporting LastShot
(FSCwire) - EQ Labs, Inc. (“EQ.” or “the Company”) (OTC.BB: EQLB), is pleased to announce that Timbaland will be Preforming Friday at Drai’s Beach club & Nightclub in Las Vegas kicking off market awareness of the new tall cranberry 8.4. oz can “Last Shot”.
Hit making mogul “Timbaland” is currently on a 20 city tour will begin supporting the branding of LastShot; through his outlets and network sources; including Facebook, Instagram, Twitter, videos, concerts tours, female reps, relationship with other mega celebrity endorsements, creating product awareness and product placement. with a national commercial by this summer.
“We are extremely pleased that Timbaland is supporting us with the branding of LastShot through his outlets and network sources” states Mo Owens, CEO of EQ Labs. “During his stay this week LastShot will be a featured product and launch the marketing of our product in Las Vegas.”
About EQ Lab, Inc.:
EQ Labs, Inc is a leader in the marketing and development of measured product release devices for the retail market. Its products will be sold through major retail stores, casinos, beverage distribution outlets and chains throughout the US. Leading products include new tall cranberry 8.4. oz. 5 Cal/2 Carbs DIETARY SUPPLEMENT ENERGIZE *HYDRATE* DETOX Last Shot 3 in 1 Hangover Protection Cranberry Cold Beverage.
Safe Harbor:
This news release contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. These forward-looking statements generally can be identified by phrases such as EQ Labs, Inc. or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new business opportunities and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report, our quarterly reports and other periodic reports filed from time-to-time with the OTC Markets.
Contact Information:
EQ Labs, Inc
Maurice Owens, President and CEO
Phone: (702) 806-5943
Web: www.Drinkeq.com
Email: mo@drinkeq.com
Twitter: eqceo
Source: EQ Labs Inc. (OTC Pink:EQLB)
Maximum News Dissemination by FSCwire. http://www.fscwire.com
Copyright © 2016 Filing Services Canada Inc.
$EQLB EQ Labs Announces Timbaland’s Appearance in Las Vegas Supporting LastShot
Source: FSCwire
EQ Labs Announces Timbaland’s Appearance in Las Vegas Supporting LastShot
(FSCwire) - EQ Labs, Inc. (“EQ.” or “the Company”) (OTC.BB: EQLB), is pleased to announce that Timbaland will be Preforming Friday at Drai’s Beach club & Nightclub in Las Vegas kicking off market awareness of the new tall cranberry 8.4. oz can “Last Shot”.
Hit making mogul “Timbaland” is currently on a 20 city tour will begin supporting the branding of LastShot; through his outlets and network sources; including Facebook, Instagram, Twitter, videos, concerts tours, female reps, relationship with other mega celebrity endorsements, creating product awareness and product placement. with a national commercial by this summer.
“We are extremely pleased that Timbaland is supporting us with the branding of LastShot through his outlets and network sources” states Mo Owens, CEO of EQ Labs. “During his stay this week LastShot will be a featured product and launch the marketing of our product in Las Vegas.”
About EQ Lab, Inc.:
EQ Labs, Inc is a leader in the marketing and development of measured product release devices for the retail market. Its products will be sold through major retail stores, casinos, beverage distribution outlets and chains throughout the US. Leading products include new tall cranberry 8.4. oz. 5 Cal/2 Carbs DIETARY SUPPLEMENT ENERGIZE *HYDRATE* DETOX Last Shot 3 in 1 Hangover Protection Cranberry Cold Beverage.
Safe Harbor:
This news release contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. These forward-looking statements generally can be identified by phrases such as EQ Labs, Inc. or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new business opportunities and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report, our quarterly reports and other periodic reports filed from time-to-time with the OTC Markets.
Contact Information:
EQ Labs, Inc
Maurice Owens, President and CEO
Phone: (702) 806-5943
Web: www.Drinkeq.com
Email: mo@drinkeq.com
Twitter: eqceo
Source: EQ Labs Inc. (OTC Pink:EQLB)
Maximum News Dissemination by FSCwire. http://www.fscwire.com
Copyright © 2016 Filing Services Canada Inc.
$PMCB Stonegate Capital Partners Publishes Research Report on PharmaCyte Biotech
http://ir.pharmacytebiotech.com/press-releases/detail/83
$PMCB Stonegate Capital Partners Publishes Research Report on PharmaCyte Biotech
http://ir.pharmacytebiotech.com/press-releases/detail/83
$USMJ USMJ: Hot Topic Around Wall Street Water Coolers: Two $30 B Market Opportunities Come Together - Cannabis and Sports Nutrition
Source: InvestorsHub NewsWire
North American Cannabis Holdings: Hot Topic Around Water Coolers On Wall Street: Bringing Two $30 Billion Market Opportunities Together - Cannabis and Sports Nutrition
New York, New York - February 10, 2016
Source: Wall Street Corner Special Situation Report
Allied Market Research published a new report titled, "World Sports Nutrition Market - Opportunities and Forecasts, 2014 – 2020," with a $33.6 billion revenue outlook for the industry in 2020 with a CAGR of 7% between now and then.
According to an article published in Inc. Magazine, the legal cannabis sector is anticipated to reach $30 billion by 2019.
The Business Insider just published an article on the benefits of cannabis to Athletic performance.
North American Cannabis Holdings, Inc.’s (USMJ) recent introduction of a cannabis infused sports and fitness nutritional supplement line of consumer products under the brand name EVERx has the makings of a major industry game changer. The Company’s plan includes plans to recruit NFL Player sponsorship. The Company has announced ongoing negotiations with an Authorized NFL Agent.
The Allied Market Research Report profiles some big players jockeying for position in the sports nutrition market to include The Coca-Cola Company (KO), Abbott Nutrition Inc (ABT), PepsiCo Inc (PEP), Glanbia plc (GLAPF), Reckitt Benckiser Group plc (RBGPF), Yakult Honsha Co., Ltd, Post Holdings, Inc (POST), GNC Holdings (GNC), Clif Bar & Company and Otsuka Pharmaceuticals Co., Ltd.
North American Cannabis Holdings anticipates getting EVERx on shelves before the end of the first quarter in 2016. EVERx is also expected to be available on line soon.
North American Cannabis Holdings, Inc. may have just discovered a blue sky opportunity. USMJ is one to watch.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
Contact:
Wall Street Corner
Larry Oakley
info@wallstreetcornerreport.com
888-509-2165 ext. 102
$USMJ USMJ: Hot Topic Around Wall Street Water Coolers: Two $30 B Market Opportunities Come Together - Cannabis and Sports Nutrition
Source: InvestorsHub NewsWire
North American Cannabis Holdings: Hot Topic Around Water Coolers On Wall Street: Bringing Two $30 Billion Market Opportunities Together - Cannabis and Sports Nutrition
New York, New York - February 10, 2016
Source: Wall Street Corner Special Situation Report
Allied Market Research published a new report titled, "World Sports Nutrition Market - Opportunities and Forecasts, 2014 – 2020," with a $33.6 billion revenue outlook for the industry in 2020 with a CAGR of 7% between now and then.
According to an article published in Inc. Magazine, the legal cannabis sector is anticipated to reach $30 billion by 2019.
The Business Insider just published an article on the benefits of cannabis to Athletic performance.
North American Cannabis Holdings, Inc.’s (USMJ) recent introduction of a cannabis infused sports and fitness nutritional supplement line of consumer products under the brand name EVERx has the makings of a major industry game changer. The Company’s plan includes plans to recruit NFL Player sponsorship. The Company has announced ongoing negotiations with an Authorized NFL Agent.
The Allied Market Research Report profiles some big players jockeying for position in the sports nutrition market to include The Coca-Cola Company (KO), Abbott Nutrition Inc (ABT), PepsiCo Inc (PEP), Glanbia plc (GLAPF), Reckitt Benckiser Group plc (RBGPF), Yakult Honsha Co., Ltd, Post Holdings, Inc (POST), GNC Holdings (GNC), Clif Bar & Company and Otsuka Pharmaceuticals Co., Ltd.
North American Cannabis Holdings anticipates getting EVERx on shelves before the end of the first quarter in 2016. EVERx is also expected to be available on line soon.
North American Cannabis Holdings, Inc. may have just discovered a blue sky opportunity. USMJ is one to watch.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.
Contact:
Wall Street Corner
Larry Oakley
info@wallstreetcornerreport.com
888-509-2165 ext. 102